Repros Therapeutics, Inc. (RPRX)

[hiwatt1959]

They should submit liver data this week and hopefully will get a decision by June 10th. Assuming a positive decision will boost stock price and allow them to sell the remainder ATM shares for another $6M. This should be enough cash to last into Q4 and the EU possible approval. Providing they execute on both drugs, another offering or partnership should follow. It's really cutting it close and that's why stock is priced at .86. I spoke with CFO last week and she wasn't in panic mode, so it kind of makes me wonder if a deal may be in the works after FDA rules on Proellex, IMO.